Excess amantadine use and resistant viruses [7]

Lancet

Volumn 358, Issue 9296, 2001, Pages 1910-

  Suzuki, Hiroshi ^a   Saito, Reiko ^a   Oshitani, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE;

ANTIBIOTIC RESISTANCE; DRUG APPROVAL; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG USE; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VIRUS; JAPAN; LETTER; MONITORING; POPULATION; PRIORITY JOURNAL; UNITED KINGDOM; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0035652644     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06919-7     Document Type: Letter

References (5)

1. Unprepared for an influenza pandemic
2. Prospects for pandemic influenza control with currently available vaccines and antivirals
3. Neuraminidase inhibitor and amantadine
4. Low incidence of rimantadine resistance in field isolates of influenza A viruses
5. Incidence of Amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan